BIOMAT Database Logo BIOMAT Database Logo

Monoclonal antibodies in the treatment of human leukemias and lymphomas: applications of flow cytometry. 1984

R A Miller, and D Maloney, and R Levy

UI MeSH Term Description Entries
D007116 Immunization, Passive Transfer of immunity from immunized to non-immune host by administration of serum antibodies, or transplantation of lymphocytes (ADOPTIVE TRANSFER). Convalescent Plasma Therapy,Immunoglobulin Therapy,Immunotherapy, Passive,Normal Serum Globulin Therapy,Passive Antibody Transfer,Passive Transfer of Immunity,Serotherapy,Passive Immunotherapy,Therapy, Immunoglobulin,Antibody Transfer, Passive,Passive Immunization,Therapy, Convalescent Plasma,Transfer, Passive Antibody
D007130 Immunoglobulin Idiotypes Unique genetically-controlled determinants present on ANTIBODIES whose specificity is limited to a single group of proteins (e.g., another antibody molecule or an individual myeloma protein). The idiotype appears to represent the antigenicity of the antigen-binding site of the antibody and to be genetically codetermined with it. The idiotypic determinants have been precisely located to the IMMUNOGLOBULIN VARIABLE REGION of both immunoglobin polypeptide chains. Idiotypes, Immunoglobulin,Ig Idiotypes,Idiotype, Ig,Idiotype, Immunoglobulin,Idiotypes, Ig,Ig Idiotype,Immunoglobulin Idiotype
D007938 Leukemia A progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. Leukemias were originally termed acute or chronic based on life expectancy but now are classified according to cellular maturity. Acute leukemias consist of predominately immature cells; chronic leukemias are composed of more mature cells. (From The Merck Manual, 2006) Leucocythaemia,Leucocythemia,Leucocythaemias,Leucocythemias,Leukemias
D008223 Lymphoma A general term for various neoplastic diseases of the lymphoid tissue. Germinoblastoma,Lymphoma, Malignant,Reticulolymphosarcoma,Sarcoma, Germinoblastic,Germinoblastic Sarcoma,Germinoblastic Sarcomas,Germinoblastomas,Lymphomas,Lymphomas, Malignant,Malignant Lymphoma,Malignant Lymphomas,Reticulolymphosarcomas,Sarcomas, Germinoblastic
D005434 Flow Cytometry Technique using an instrument system for making, processing, and displaying one or more measurements on individual cells obtained from a cell suspension. Cells are usually stained with one or more fluorescent dyes specific to cell components of interest, e.g., DNA, and fluorescence of each cell is measured as it rapidly transverses the excitation beam (laser or mercury arc lamp). Fluorescence provides a quantitative measure of various biochemical and biophysical properties of the cell, as well as a basis for cell sorting. Other measurable optical parameters include light absorption and light scattering, the latter being applicable to the measurement of cell size, shape, density, granularity, and stain uptake. Cytofluorometry, Flow,Cytometry, Flow,Flow Microfluorimetry,Fluorescence-Activated Cell Sorting,Microfluorometry, Flow,Cell Sorting, Fluorescence-Activated,Cell Sortings, Fluorescence-Activated,Cytofluorometries, Flow,Cytometries, Flow,Flow Cytofluorometries,Flow Cytofluorometry,Flow Cytometries,Flow Microfluorometries,Flow Microfluorometry,Fluorescence Activated Cell Sorting,Fluorescence-Activated Cell Sortings,Microfluorimetry, Flow,Microfluorometries, Flow,Sorting, Fluorescence-Activated Cell,Sortings, Fluorescence-Activated Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000911 Antibodies, Monoclonal Antibodies produced by a single clone of cells. Monoclonal Antibodies,Monoclonal Antibody,Antibody, Monoclonal
D000951 Antigens, Neoplasm Proteins, glycoprotein, or lipoprotein moieties on surfaces of tumor cells that are usually identified by monoclonal antibodies. Many of these are of either embryonic or viral origin. Neoplasm Antigens,Tumor Antigen,Tumor Antigens,Antigen, Tumor,Antigens, Tumor

Related Publications

R A Miller, and D Maloney, and R Levy
Diagnosis and treatment of human leukemias and lymphomas utilizing monoclonal antibodies.
January 1981, Progress in hematology,
R A Miller, and D Maloney, and R Levy
Laboratory and clinical applications of monoclonal antibodies for leukemias and non-Hodgkin's lymphomas.
January 1989, Current problems in cancer,
R A Miller, and D Maloney, and R Levy
[Monoclonal antibodies for lymphomas and leukemias in 2005].
January 2006, Bulletin du cancer,
R A Miller, and D Maloney, and R Levy
Mouse monoclonal antibodies against human c-Mpl and characterization for flow cytometry applications.
April 2010, Hybridoma (2005),
R A Miller, and D Maloney, and R Levy
[Flow cytometric analysis of malignant cells in lymphocytic leukemias and lymphomas by monoclonal antibodies].
August 1988, [Rinsho ketsueki] The Japanese journal of clinical hematology,
R A Miller, and D Maloney, and R Levy
The generation of monoclonal anti-idiotype antibodies to human B cell-derived leukemias and lymphomas.
July 1985, Journal of immunology (Baltimore, Md. : 1950),
R A Miller, and D Maloney, and R Levy
Human lymphocyte subpopulations: analysis by multiparameter flow cytometry and monoclonal antibodies.
January 1987, Cancer detection and prevention. Supplement : official publication of the International Society for Preventive Oncology, Inc,
R A Miller, and D Maloney, and R Levy
Monoclonal antibodies in the treatment of myelogenous leukemias.
January 1993, Cancer treatment and research,
R A Miller, and D Maloney, and R Levy
A knowledge-based system for the interpretation of flow cytometry data in leukemias and lymphomas.
November 1994, Cytometry,
R A Miller, and D Maloney, and R Levy
Monoclonal antibodies in the treatment of chronic lymphoid leukemias.
February 2004, Leukemia & lymphoma,
Copied contents to your clipboard!